Navigation Links
Lilly Reports Second-Quarter 2011 Results
Date:7/21/2011

ond Quarter

% Change
Over/(Under)

Year-to-Date

% Change
Over/(Under)20112010

2010

2011

2010

2010Zyprexa®

$1,408.3$1,262.912%$2,690.1$2,477.99%Cymbalta

1,003.4867.716%1,912.11,670.914%Alimta®

613.4551.811%1,193.31,079.211%Humalog®

586.9504.616%1,112.31,011.010%Cialis®

477.2418.714%911.6827.010%Humulin®

311.8265.218%601.7523.015%Evista®

263.5259.52%529.6501.16%Forteo®

231.0209.610%447.0404.111%Strattera®

157.7147.17%296.4293.51%Gemzar

112.4293.4(62)%268.5581.2(54)%Animal Health

389.5324.220%759.3613.824%Total Revenue

$6,252.8$5,748.79%$12,092.0$11,234.28%Zyprexa

In the second quarter of 2011, Zyprexa sales totaled $1.408 billion, an increase of 12 percent compared with the second quarter of 2010.  U.S. sales of Zyprexa increased 11 percent to $711.2 million, driven by higher prices. Zyprexa sales in international markets increased 12 percent, to $697.1 million, driven primarily by the favorable impact of foreign exchange rates. The company will lose patent exclusivity for Zyprexa in the U.S. in October 2011 and in most of Europe in September 2011. While it is difficult to predict the precise timing and magnitude of the impact on Zyprexa sales, the company expects the introduction of generics to result in a rapid and severe decline in Zyprexa sales.  

Cymbalta

For the second quarter of 2011, Cymbalta generated $1.003 billion in revenue, an increase of 16 percent compared with the second quarter of 2010. U.S. sales of Cymbalta increased 7 percent, to $758.4 million, driven by increased demand, and to a lesser extent, higher net effective selling prices. Sales outside the U.S. were $245.0 million, an increase of 53 percent, driven primarily by higher demand in international markets, the 2010 launch in Japan, and, to a lesser extent, the favorable impact of foreign
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimers Disease Research
2. Lilly and Argonne National Laboratory Announce $2 Million Upgrade to Lillys Beamline Capabilities
3. Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer
4. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
5. Lilly CEO Calls for Improved Dialogue in Germany Between Industry and the Government and Health Care System
6. Lilly Quality Leader Walsh Appointed to Companys Executive Committee
7. Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations
8. Lilly Announces New Investment to Further Boost Its Biotechnology Capabilities
9. Lilly Declares Third-Quarter 2011 Dividend
10. Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform
11. Synthes and Lilly Sign Development and Collaboration Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 Konica Minolta ... announced today a new, integrated portable X-ray ... solution is now available with a larger integrated console, ... mounted system offers a larger viewing area to simplify ... provides additional space for accessories and storage, along with ...
(Date:3/3/2015)... 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... Company"), a specialty pharmaceutical company focused on pharmaceuticals for ... the 27th Annual ROTH Conference, which will take place ... Dana Point, California . Management,s presentation ... a.m. Pacific Time (12:00 p.m. Eastern Time) in the ...
(Date:3/3/2015)... 2015  Web Industries, Inc., a leading provider ... Medical Device, Advanced Composites, Consumer Products, and Wire ... Medical Specialties Preferred Converter by 3M,s Medical Specialties ... to streamline their supply chains by using Web ... materials, intermediate converting services, and contract manufacturing and ...
Breaking Medicine Technology:Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 2Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 3Web Industries Receives 3M Preferred Converter Status 2
... advanced leukemia and myelodysplastic, syndrome patients presented ... N.J., Dec. 10 Celator Pharmaceuticals today,announced results ... a liposomal,formulation that incorporates a synergistic ratio of ... and myelodysplastic,syndromes. While dose escalation in the study ...
... Dec. 10 The US Food and,Drug Administration ... small,open, long-term, clinical studies in patients with gastro-esophageal ... study) or NEXIUM(R) (LOTUS study) treatment., AstraZeneca ... conclusion which states,"FDA continues to conclude that long-term ...
Cached Medicine Technology:Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 3FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 4
(Date:3/3/2015)... Daylight Savings Time may lead to your kids ... for parents. , Parents and their children may feel a ... they set their clocks forward one hour for Daylight Savings ... one hour earlier -- you will have already lost one ... about “sleep hygiene” for their kids and teens this week, ...
(Date:3/3/2015)... 03, 2015 Topical BioMedics, Inc., announces its ... streamed live on Tuesday, March 10th, 12pm – 1pm and ... and accessible 24/7. , The Pain Management ... for the March 10th workshop is “Opioid Addiction: An ... the U.S. represents 5% of the world’s population, yet consumers ...
(Date:3/3/2015)... MD (PRWEB) March 03, 2015 Today ... Association (ASHA) is using the occasion to applaud and ... campaign by the World Health Organization (WHO) for stemming ... campaign aims to encourage young people to practice safe ... audio technology, attending concerts or sporting events, or engaging ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The ... better predict antidepressant treatment outcomes for patients with ... than any of the individual genes that comprise ... investigators from the Mayo Clinic and Assurex Health, ... , The proprietary technology of the GeneSight ...
(Date:3/3/2015)... With a grant of more than $4.5 ... has been named a national coordinating center by the ... for Health: Improving Community Health Through Innovations in Financing ... health and reduce disparities through innovations in collaboration and ... of the center and up to 10 communities over ...
Breaking Medicine News(10 mins):Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:Robert Wood Johnson Foundation Names Georgia Health Policy Center National Center for Bridging for Health Initiative 2
... have now proved using a specialized mouse model that ... neurons.// The results of this study have for the ... ,Also known as apoE, this cholesterol-carrying protein ... the major known genetic risk factor for Alzheimer's disease, ...
... published in the journal Carcinogenesis show that exercise can offer ... that had a round the clock access to wheels took ... that exercise and a restricted diet had a healthy effect ... ,The first study exposed mice to ultraviolet B ...
... Dental Health Foundation has found that more than 60 percent ... clean off food debris// struck in between their teeth. Items ... use, the survey said. ,More disturbingly, the survey ... teeth giving rise to oral health problems and bad breath. ...
... the form of health claims that green tea is no ... a model qualified health// claim says "Daily consumption of at ... a source of catechins may reduce a number of risk ... evidence is supportive, but not conclusive, for this claim. (Green ...
... (AIIMS) here is running short of faculty members and its ... informed Friday. ,Replying to a question, minister of state ... AIIMS was running with just 479 faculty members as against ... the house that during 2003-05, 20 faculty members had either ...
... rate in Madhya Pradesh, Bhopal Archbishop Pascal Topno has ... ,With 13,000 reported deaths every year during or ... is one of the highest in the country. ... Niketan Welfare Centre here, Topno urged them to tap ...
Cached Medicine News:Health News:Alzheimer's-linked apolipoprotein E produced by neurons, Gladstone study 2Health News:Green tea’s health claims questioned: FD 2Health News:Green tea’s health claims questioned: FD 3
Cushing bayonet....
Straight, blunt tips....
Angled, pointed, with attached cable for Valleylab and other brands generators....
Autoclavable reusable pencil for Aaron 800 & 1200 - comes with generator or 1/box....
Medicine Products: